Randomized controlled trials of transcatheter aortic valve replacement (TAVR) included both transfemoral and alternative access approaches for valve delivery (1), but the best outcome, superiority to surgical aortic valve replacement, was only achieved in transfemoral patients (2,3). Unfortunately, a significant number of patients remain ineligible for routine transfemoral access due to peripheral arterial disease, which precludes delivery of large-diameter transcatheter valve delivery systems
A Prospective Registry of Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement / Di Mario C.; Goodwin M.; Ristalli F.; Ravani M.; Meucci F.; Stolcova M.; Sardella G.; Salvi N.; Bedogni F.; Berti S.; Babaliaros V.C.; Pop A.; Caparrelli D.; Stewart J.; Devireddy C.. - In: JACC: CARDIOVASCULAR INTERVENTIONS. - ISSN 1936-8798. - ELETTRONICO. - 12:(2019), pp. 502-504. [10.1016/j.jcin.2019.01.211]
A Prospective Registry of Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement
Di Mario C.
;
2019
Abstract
Randomized controlled trials of transcatheter aortic valve replacement (TAVR) included both transfemoral and alternative access approaches for valve delivery (1), but the best outcome, superiority to surgical aortic valve replacement, was only achieved in transfemoral patients (2,3). Unfortunately, a significant number of patients remain ineligible for routine transfemoral access due to peripheral arterial disease, which precludes delivery of large-diameter transcatheter valve delivery systemsFile | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1936879819302729-main.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
101.42 kB
Formato
Adobe PDF
|
101.42 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.